Study 203121: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Atopic Dermatitis
Phase of Trial: Phase II
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Tapinarof (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 20 Mar 2017 Status changed from recruiting to completed.
- 19 Jan 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Jan 2017.
- 08 Aug 2016 Planned End Date changed from 1 Oct 2016 to 1 Jan 2017.